Treatment of ASCVD Risk: From Lifestyle to Advanced Therapies

This episode of CardiaCast will feature a discussion on the treatment of atherosclerotic cardiovascular disease (ASCVD) risk – from lifestyle to advanced therapies, led by Dr. Maya Safarova. The conversation covers lifestyle "therapy", the treatment algorithm for primary and secondary prevention, and what's on the horizon for ASCVD.

This podcast is supported by Esperion, Merck, and Novartis.